Evidence map›Paper›PMID 41960810›Full record

ArticlePharmacoepidemiology and drug safety2026

Factors Associated With Self-Medication to Mitigate Vaccine Reactions After COVID-19 Vaccination: A Prospective Cohort Study.

Maximilian Blattner, Ingmar Schäfer, Yvonne Nestoriuc, Christian Büchel, Martin Scherer, Jan Hendrik Oltrogge-Abiry

Abstract read
In one paragraph

Article in Pharmacoepidemiology and drug safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maximilian BlattnerDepartment of General Practice and Primary Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ingmar SchäferDepartment of General Practice and Primary Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID https://orcid.org/0000-0002-1038-7478
Yvonne NestoriucClinical Psychology and Psychotherapy, Helmut-Schmidt-University/University of the Federal Armed Forces Hamburg, Hamburg, Germany.
Christian BüchelInstitute of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Martin SchererDepartment of General Practice and Primary Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jan Hendrik Oltrogge-AbiryDepartment of General Practice and Primary Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID https://orcid.org/0000-0003-0062-1715

Funding

Deutsche Forschungsgemeinschaft 422744262Universitätsklinikum Hamburg-Eppendorf
6 · The paper itself

Abstract

objectiveManagement of vaccine reactions with analgesics/antipyretics can enhance acceptance and adherence to future vaccinations. However, inappropriate self-medication may pose health risks, particularly for individuals with chronic conditions. The aim of this study was to identify demographic, clinical, and psychosocial factors associated with self-medication behavior after COVID-19 vaccinations.

methodsMonocentric prospective cohort study at a vaccination center in Germany between August 16 and 28, 2021 with adults receiving a second dose of mRNA-based COVID-19 vaccines. We used linear regression analyses to examine the association of self-reported factors with the amount of self-medication after vaccination.

resultsA total of 1616 participants (median age 34 years, 52% females) were included, with 536 (33.2%) reporting the use of self-medication. Used substances were nonsteroidal anti-inflammatory drugs n = 345 (21.3%), paracetamol n = 186 (11.5%), acetylsalicylic acid n = 48 (3.0%), and metamizole n = 18 (1.1%). The highest intake of any analgesic/antipyretic was observed on the first day after vaccination n = 393 (24.3%). Factors associated with increased self-medication included premedication with analgesics/antipyretics (B: 0.545; 95% CI: 0.442; 0.651), administration of the mRNA-1273-vaccine compared to the BNT162b2-vaccine (B: 0.293; 95% CI: 0.188; 0.397), female gender (B: 0.159; 95% CI: 0.07; 0.249), prior experiences of vaccine reactions (B:0.117; 95% CI: 0.054; 0.18), expectations of vaccine reactions (B: 0.063; 95% CI: 0.003; 0.123), and the presence of common chronic conditions. A higher satisfaction with the vaccination process (B: -0.129; 95% CI: -0.222; -0.039) was associated with lower rates of self-medication.

conclusionsFactors influencing self-medication behavior after vaccination exist and could be assessed prior to vaccine administration. The observed association of previous experiences as well as expectations of vaccine reactions suggests that nocebo effects contribute to self-medication practices.

Indexed as

COVID-19COVID-19 VaccinesSelf MedicationVaccinationAdultCohort StudiesFemaleGermanyHumansMaleMiddle AgedProspective StudiesCOVID-19 Vaccinesnonprescription drugspatient reported outcome measuresprimary health careprospective cohort studiesquality in health careself medication

Identifiers

PMID41960810
PMCPMC13067796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.